Program

09.30	Open virtual conference room and Welcome
10.00	Prof. Jean-Louis Reymond, University of Bern, Switzerland «The peptide chemical space as tool for discovery and optimization»
10.30	Dr. Pottayil G Sasikumar, Aurigene Discovery Technologies Ltd, India «Discovery of peptide inspired orally bioavailable drugs for cancer immunotherapy»
11.00	Break
11.30	Dr. Dominic Höpfner & Dr. Jürg Hunziker, Novartis Pharma AG, Switzerland «Target fishing with peptide natural products by chemogenomics»
12.00	Prof. Ali Tavassoli, University of Southampton, UK «Platforms for the generation and high-throughput screening of Microcycle libraries for inhibitors of protein-protein interactions»
12.30	Lunch break, Exhibition online room
14.00	Plenary Lecture Prof. Fernando Albericio, University of Kwazulu-Natal, South Africa «Peptides from the Nature to the Laboratory»
15.00	Break
15.30	Dr. Sebastien Dutertre, CNRS University of Montpellier, France «Backbone cyclization turns a venom peptide into a stable and equipotent ligand at both muscle and neuronal nicotinic receptors»
16.00	Prof. Mandë Holford, Hunter College, New York, USA «Venom Peptides Attack Cancer Using a Channelopathy Strategy»
16.30	Prof. Annette Beck-Sickinger, University of Leipzig, Germany «G protein coupled peptide receptors - State of the art and innovative therapeutic concepts»
17.00	Dr. Hans Melo, Menten Biotechnology Labs, Canada «Designing peptides on a quantum computer»
17.30	End of Day 1

10.00	Dr. Dominik Sarma, Belyntic, Germany «Parallel manufacturing of AI-predicted peptide epitopes for vaccination against the SARS-CoV-2 virus»
10.30	Dr. Simone Schadt, F. Hoffmann-La Roche AG, Switzerland «Biotransformation of peptide drugs»
11.00	Break
11.30	Dr. Armin Bauer, Sanofi-Aventis Deutschland GmbH, Germany «Synthesis and optimization of non-ribosomal peptide antibiotics»
12.00	Prof. Stephan Urban, University of Heidelberg, Germany «Can a peptide cure chronically infected Hepatitis B and D patients? Recent clinical results on Myrcludex B/bulevirtide»
12.30	Lunch break, Exhibition online room
14.00	Dr. Christian Schwarz, NUMAFERM GmbH, Germany «The white spot of biotechnology – medium to long chained peptides»
14.30	Michael Wagner, Sanofi-Aventis Deutschland GmbH, Germany «Chemical Probes for the Discovery and Development of Peptide Therapeutics»
15.00	Break
15.30	Dr. Theodosia Maina-Nock, Molecular Radiopharmacy, NCSR Demokritos, Greece «Radiolabeled bombesin and gastrin analogs in cancer theranostics: Developments at NCSR "Demokritos"»
16.00	Dr. Mike Pennington, AmbioPharm, USA «Cell penetrating plant peptide targets Kv1.3 and inhibits effector memory T-cells»
16.30	Dr. Joel P. Schneider, National Cancer Institute, USA «Peptide-based materials for miRNA delivery and the treatment of mesothelioma»
17.00	End of the Peptide Therapeutics Symposium 2020